Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

<p><strong>Background</strong> Immune checkpoint inhibitors (ICI) improve survival but cause immune-related adverse events (irAE). We sought to determine if CTCAE classification, IBD biomarkers/endoscopic/histological scores correlate with irAE colitis outcomes.</p> <p>...

Description complète

Détails bibliographiques
Auteurs principaux: Cheung, VTF, Gupta, T, Olsson-Brown, A, Subramanian, S, Sasson, SC, Heseltine, J, Fryer, E, Collantes, E, Sacco, JJ, Pirmohamed, M, Simmons, A, Klenerman, P, Tuthill, M, Protheroe, AS, Chitnis, M, Fairfax, BP, Payne, MJ, Middleton, MR, Brain, O
Format: Journal article
Langue:English
Publié: Springer Nature 2020

Documents similaires

Documents similaires